| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,915 |
1,509 |
$463K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
260 |
204 |
$178K |
| 92134 |
|
3,166 |
2,745 |
$91K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,101 |
802 |
$65K |
| 92226 |
|
1,018 |
599 |
$43K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
513 |
501 |
$17K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
248 |
222 |
$10K |
| 92202 |
|
806 |
721 |
$10K |
| 92225 |
|
95 |
48 |
$4K |
| 92201 |
|
133 |
112 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34 |
32 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
12 |
$804.71 |
| 4040F |
|
1,395 |
1,145 |
$0.07 |
| 1036F |
|
1,265 |
1,051 |
$0.07 |
| G8482 |
Influenza immunization administered or previously received |
659 |
551 |
$0.06 |
| 2022F |
|
841 |
659 |
$0.04 |
| 2021F |
|
792 |
614 |
$0.03 |
| 5010F |
|
791 |
613 |
$0.03 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
15 |
13 |
$0.00 |
| 4177F |
|
15 |
13 |
$0.00 |